Skip to main content
Caplight Logo









CelluForce

CelluForce

Private
MontrealFrontier & Industrial Techhttps://celluforce.com/

Last Round

Grant

Sep 22, 2025

Est. Valuation

$47.25M

Total Funding Raised

$11.99M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

CelluForce is a biomaterials company that produces and commercializes cellulose nanocrystals for use in various industrial applications.

Sector

Frontier & Industrial Tech

Verticals

Advanced Materials, Sustainable Materials, Clean Manufacturing

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting, Government Contracts

AI Layer

Non-AI

Keywords

cellulose nanocrystalsCNCadvanced biomaterialnanocellulosebio-based additivesustainable materialschemical manufacturingperformance additivebarrier coatingmaterials sciencebiochemicalsviscosity modifierwood pulp derivativecosmetics ingredientspackaging materials

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

CelluForce Comparables

Compare CelluForce with similar companies based on industry and business-model similarity.

CelluForce comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Anomera
89%
CelluComp
82%
ANPOLY Inc.
82%

CelluForce Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantSep 22, 2025
GrantFeb 5, 2019
VC RoundFeb 5, 2019
StrategicNov 21, 2016
StrategicMar 25, 2015
Grant
Feb 16, 2015

Key People

Founding team and executive leadership

Sebastien Corbeil

President And CEO

Executive Team

Richard Berry

Chief Technology Officer

Executive Team

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 21, 2026

    Monthly visitors grew 167% MoM, reaching 3.4K.

  • Sep 22, 2025

    Launched CelluShield, a bio-based barrier coating for recyclable packaging.

CelluForce Filings

Explore SEC and related filing metadata, where available.

CelluForce filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about CelluForce's valuation, stock price, and market status.

Is CelluForce a public or private company?

CelluForce is a private company.

What is the current stock price of CelluForce?

CelluForce is a private company with no public stock price. No recent secondary market data is available.

How much is CelluForce worth (valuation)?

CelluForce's valuation is estimated at $47.3M based on funding round data.

Can I buy CelluForce stock?

CelluForce shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was CelluForce's last funding round?

CelluForce's most recent funding round was Grant on November 21, 2016.

Who are the main investors in CelluForce?

Key investors in CelluForce include Investissement Québec, Sustainable Development Technology Canada, National Research Council Canada Industrial Research Assistance Program, FPInnovations, Gouvernement du Québec.

Will CelluForce IPO soon?

No public IPO plans have been announced for CelluForce.

How can I track CelluForce secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor CelluForce's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersMontreal
Employee Range16
Year Founded2010
Last FundingSep 22, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?